be_ixf;ym_202512 d_16; ct_50

Latest Insights on LIM

For Seasoned Traders — 3 More Ways to Get Happy Rich This Year! February 8, 2020 by Kristen Barrett American Investor Today, Diversified Investments This week, we share four trading strategies that seasoned traders can follow to get “happy rich” in 2020. Strategy No. 1: Don’t lose money trying to guess earnings. Chad Shoop will show you how to profit from earnings after companies report. Strategy No. 2: Forget bonds and dividends for income. Chad Shoop has an income strategy that boasts a 97% win rate! Strategy No. 3: Natural resources such as oil and copper are volatile. But Matt Badiali and John Ross have a system to profit from the boom-bust cycle.
Don’t Drink the Tesla Kool-Aid — Here’s a Smarter Buy February 7, 2020 by Anthony Planas American Investor Today, Stocks Tesla shares surged to nearly $1,000 on Tuesday. But the carmaker’s rally is a sign of euphoria for growth stocks. And that’s bad news for future returns. Anthony Planas tells you why you need to park your money in a forgotten sector.
david and goliath amazon Amazon’s $1 Trillion Playbook: How to Buy the Next Market Disruptor February 6, 2020 by Charles Mizrahi American Investor Today, Trading Strategies Today, Amazon and Netflix are known as industry disruptors. But in their early days, they were considered underdogs going up against giant brick-and-mortar retail chains. Today, Charles Mizrahi uncovers the one secret that underpins “underdogs” such as Netflix and Amazon.
Make 35% by July 4 With Exxon Mobil February 5, 2020 by John Ross American Investor Today, Oil Wall Street is dumping this energy giant over a tough quarter. John Ross shares how to make 26% on Exxon's rally by Independence Day.
abbvie stock Profit From AbbVie’s Struggles Today February 4, 2020 by Chad Shoop American Investor Today, Stocks Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“Loving this. Should have started a long time ago.”

- Jay

Share This